Table 1.
Distribution of clinical characteristics of ovarian cancer patients included in the study.
| N | % | |||
|---|---|---|---|---|
| Total |
70 | 100.0 | ||
| FIGO Stage |
||||
| Stage I | 23 | 32.9 | ||
| Stage II | 11 | 15.7 | ||
| Stage III | 29 | 41.4 | ||
| Stage IV | 7 | 10.0 | ||
| Tumor Type |
||||
| Serous | 26 | 37.1 | ||
| Clear Cell | 17 | 24.3 | ||
| Endometriod | 17 | 24.3 | ||
| Mucinous | 6 | 8.6 | ||
| Transitional | 4 | 5.7 | ||
| Tumor Grade |
||||
| Grade 1 | 7 | 10.0 | ||
| Grade 2 | 22 | 31.4 | ||
| Grade 3 | 39 | 55.7 | ||
| Missing | 2 | 2.9 | ||
| nYap |
||||
| Low | 42 | 60.0 | ||
| High | 25 | 35.7 | ||
| Missing | 3 | 4.3 | ||
| cpYap |
||||
| Low | 39 | 55.7 | ||
| High | 28 | 40.0 | ||
| Missing | 3 | 4.3 | ||
| nY/cpY Category |
||||
| nYap | cpYap | |||
| 0 | low | high | 22 | 31.4 |
| 1 | low | low | 19 | 27.1 |
| 2 | high | high | 6 | 8.6 |
| 3 | high | low | 18 | 25.7 |
| Missing | 5 | 7.1 | ||
nY/cpY Category 0 =low nYap, high cpYap, 1 = low nYap, low cpYap, 2 = high nYap, high cpYap, and 3=high nYap, low cpYap. FIGO = International Federation of Gynecology and Obstetrics.